Perincheri Sudhir
Department of Pathology, Yale School of Medicine, 310 Cedar Street, Suite LB20, New Haven, CT 06510, USA.
Surg Pathol Clin. 2019 Sep;12(3):719-731. doi: 10.1016/j.path.2019.03.004. Epub 2019 May 15.
Technical advances in diagnostic modalities have led to the characterization of indolent lymphoid disorders similar to the in situ lesions described in epithelial malignancies. These early and indolent lymphoid lesions share clinicopathologic characteristics with well-characterized lymphoid malignancies such as chronic lymphocytic leukemia and follicular lymphoma. The in situ lesions have an indolent clinical course with only a minor subset shown to progress to frank malignancies. In addition to the in situ lesions, new indolent lymphoproliferative disorders have been recently characterized. Diagnosis and characterization of these indolent lesions is necessary to prevent overtreatment with aggressive therapeutic regimens.
诊断方式的技术进步已促成对惰性淋巴样疾病的特征描述,这些疾病类似于上皮恶性肿瘤中所描述的原位病变。这些早期的惰性淋巴样病变与已明确特征的淋巴样恶性肿瘤(如慢性淋巴细胞白血病和滤泡性淋巴瘤)具有临床病理特征。原位病变具有惰性临床病程,只有一小部分会进展为明显的恶性肿瘤。除原位病变外,最近还对新的惰性淋巴增殖性疾病进行了特征描述。对这些惰性病变进行诊断和特征描述对于防止采用激进治疗方案过度治疗是必要的。